We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

BIO-RAD LABORATORIES

Provides full range of instrumentation, reagent kits, software and quality control systems to clinical laboratories. ... read more Featured Products: More products

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Bio-Rad Launches RT-PCR Assays to Track SARS-CoV-2 Variants More Rapidly and Cost-Effectively

By LabMedica International staff writers
Posted on 22 Apr 2021
Print article
Illustration
Illustration
Bio-Rad Laboratories (Hercules, CA, USA) has launched the SARS-CoV-2 Variant RT-PCR Assays for research use only (RUO).

The assays can detect SARS-CoV-2 (the virus associated with COVID-19) variants of concern, including P.1, B.1.351, and B.1.1.7, by distinguishing specific mutations in SARS-CoV-2 using reverse transcription PCR (RT-PCR) often prior to a next generation sequencing (NGS) workflow for confirmation.

With the emergence of several SARS-CoV-2 variants of concern, public health researchers are looking for a quicker way to track the spread of these variants in a population. Laboratories that use NGS to track COVID-19 variants can detect these mutations more quickly and cost-effectively with the SARS-CoV-2 Variant RT-PCR Assays to more rapidly prioritize which samples to submit for NGS.

"We are pleased to introduce our SARS-CoV-2 Variant RT-PCR Assays to enable detection of mutations in these new variants more quickly and cost-effectively by laboratories using NGS to track COVID-19 variants," said John Randall, Bio-Rad Vice President Marketing, Life Science Group. “The assays join Bio-Rad’s offering of research and testing products that are helping in the fight against COVID-19.”



New
Gold Supplier
SARS-CoV2 Antigen Rapid Test
SARS-CoV2 Antigen Rapid Test
New
COVID-19 POC Test
FREND COVID-19 SP
New
Molecular Diagnostics System
ePlex System
New
Gold Supplier
Nucleic Acid Extraction System
SMPE-960

Print article

Channels

Molecular Diagnostics

view channel
Image: The Lumipulse G β-amyloid 1-40 assay kit (Photo courtesy Fujirebio)

APOE Gene Influences Alzheimer's Symptoms, Biomarkers in Down Syndrome

Individuals with Down syndrome (DS) constitute a population at ultrahigh risk of developing Alzheimer disease (AD) because of trisomy of chromosome 21, which harbors the amyloid precursor protein (APP) gene.... Read more

Industry

view channel
Illustration

ELITechGroup Acquires Freezing Point Osmometry Provider GONOTEC

ELITechGroup (Puteaux, France) has acquired GONOTEC (Berlin, Germany), thus uniting two osmometry market leaders. The acquisition will also provides the industry with a full range of osmometry solutions... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.